A Multicentre Hospital Outbreak in Sweden Caused by Introduction of a vanB2 Transposon into a Stably Maintained pRUM-Plasmid in an Enterococcus faecium ST192 Clone

The clonal dissemination of VanB-type vancomycin-resistant Enterococcus faecium (VREfm) strains in three Swedish hospitals between 2007 and 2011 prompted further analysis to reveal the possible origin and molecular characteristics of the outbreak strain. A representative subset of VREfm isolates (n = 18) and vancomycin-susceptible E. faecium (VSEfm, n = 2) reflecting the spread in time and location was approached by an array of methods including: selective whole genome sequencing (WGS; n = 3), multi locus sequence typing (MLST), antimicrobial susceptibility testing, virulence gene profiling, identification of mobile genetic elements conferring glycopeptide resistance and their ability to support glycopeptide resistance transfer. In addition, a single VREfm strain with an unrelated PFGE pattern collected prior to the outbreak was examined by WGS. MLST revealed a predominance of ST192, belonging to a hospital adapted high-risk lineage harbouring several known virulence determinants (n≥10). The VREfm outbreak strain was resistant to ampicillin, gentamicin, ciprofloxacin and vancomycin, and susceptible to teicoplanin. Consistently, a vanB2-subtype as part of Tn1549/Tn5382 with a unique genetic signature was identified in the VREfm outbreak strains. Moreover, Southern blot hybridisation analyses of PFGE separated S1 nuclease-restricted total DNAs and filter mating experiments showed that vanB2-Tn1549/Tn5382 was located in a 70-kb sized rep 17/pRUM plasmid readily transferable between E. faecium. This plasmid contained an axe-txe toxin-antitoxin module associated with stable maintenance. The two clonally related VSEfm harboured a 40 kb rep 17/pRUM plasmid absent of the 30 kb vanB2-Tn1549/Tn5382 gene complex. Otherwise, these two isolates were similar to the VREfm outbreak strain in virulence- and resistance profile. In conclusion, our observations support that the origin of the multicentre outbreak was caused by an introduction of vanB2-Tn1549/Tn5382 into a rep 17/pRUM plasmid harboured in a pre-existing high-risk E. faecium ST192 clone. The subsequent dissemination of VREfm to other centres was primarily caused by clonal spread rather than plasmid transfer to pre-existing high-risk clones.

[1]  Patrice Courvalin,et al.  Vancomycin resistance in gram-positive cocci. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Cesar A. Arias,et al.  The rise of the Enterococcus: beyond vancomycin resistance , 2012, Nature Reviews Microbiology.

[3]  T. Mikalsen,et al.  Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  K. Nielsen,et al.  Persistence of Animal and Human Glycopeptide-Resistant Enterococci on Two Norwegian Poultry Farms Formerly Exposed to Avoparcin Is Associated with a Widespread Plasmid-Mediated vanA Element within a Polyclonal Enterococcus faecium Population , 2005, Applied and Environmental Microbiology.

[5]  M. D. Kraker,et al.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  P. Sisson,et al.  DNA Banding Pattern Polymorphism in Vancomycin-Resistant Enterococcus faecium and Criteria for Defining Strains , 1999, Journal of Clinical Microbiology.

[7]  P. Trieu-Cuot,et al.  Heterogeneric conjugal transfer of the pheromone-responsive plasmid pIP964 (IncHlyI) of Enterococcus faecalis in the apparent absence of pheromone induction. , 1994, FEMS microbiology letters.

[8]  Torsten Seemann,et al.  Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci , 2013, mBio.

[9]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[10]  W. van Schaik,et al.  Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era. , 2013, Current opinion in microbiology.

[11]  Torsten Seemann,et al.  A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. , 2010, The Journal of infectious diseases.

[12]  W. Hanage,et al.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. , 2011, FEMS microbiology reviews.

[13]  H. Goossens,et al.  A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. , 2003, The Journal of infectious diseases.

[14]  Johanna C. Braat,et al.  SgrA, a Nidogen-Binding LPXTG Surface Adhesin Implicated in Biofilm Formation, and EcbA, a Collagen Binding MSCRAMM, Are Two Novel Adhesins of Hospital-Acquired Enterococcus faecium , 2009, Infection and Immunity.

[15]  J. Corander,et al.  Restricted Gene Flow among Hospital Subpopulations of Enterococcus faecium , 2012, mBio.

[16]  F. Baquero,et al.  Microevolutionary Events Involving Narrow Host Plasmids Influences Local Fixation of Vancomycin-Resistance in Enterococcus Populations , 2013, PloS one.

[17]  F. Aarestrup,et al.  A classification system for plasmids from enterococci and other Gram-positive bacteria. , 2010, Journal of microbiological methods.

[18]  K. Nielsen,et al.  PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems. , 2010, FEMS immunology and medical microbiology.

[19]  D. Tribe,et al.  Multilocus Sequence Typing Scheme for Enterococcus faecium , 2002, Journal of Clinical Microbiology.

[20]  A. Sundsfjord,et al.  ICESluvan, a 94-Kilobase Mosaic Integrative Conjugative Element Conferring Interspecies Transfer of VanB-Type Glycopeptide Resistance, a Novel Bacitracin Resistance Locus, and a Toxin-Antitoxin Stabilization System , 2013, Journal of bacteriology.

[21]  Kavindra V. Singh,et al.  A Functional Collagen Adhesin Gene, acm, in Clinical Isolates of Enterococcus faecium Correlates with the Recent Success of This Emerging Nosocomial Pathogen , 2008, Infection and Immunity.

[22]  M. Teuber,et al.  Sequence of the 50-kb conjugative multiresistance plasmid pRE25 from Enterococcus faecalis RE25. , 2001, Plasmid.

[23]  F. Baquero,et al.  Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex , 2005, Emerging infectious diseases.

[24]  A. Sundsfjord,et al.  Heterogeneity in the vanB Gene Cluster of Genomically Diverse Clinical Strains of Vancomycin-Resistant Enterococci , 1999, Antimicrobial Agents and Chemotherapy.

[25]  R. Leclercq,et al.  d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium , 2011, Antimicrobial Agents and Chemotherapy.

[26]  A. Sundsfjord,et al.  Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study , 2014, Journal of Clinical Microbiology.

[27]  K. Kidd‐Ljunggren,et al.  Alarming spread of vancomycin resistant enterococci in Sweden since 2007. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  M. Bonten,et al.  Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. , 2008, Microbiology.

[29]  J. Townsend,et al.  Factors affecting the reversal of antimicrobial-drug resistance. , 2009, The Lancet. Infectious diseases.

[30]  N. Perna,et al.  progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.

[31]  R. Saldanha,et al.  RNA and protein catalysis in group II intron splicing and mobility reactions using purified components. , 1999, Biochemistry.

[32]  G. Weinstock,et al.  Clinical isolates of Enterococcus faecium exhibit strain‐specific collagen binding mediated by Acm, a new member of the MSCRAMM family , 2003, Molecular microbiology.

[33]  Paul D. R. Johnson,et al.  Transfer of Vancomycin Resistance Transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the Gut of Gnotobiotic Mice , 2006, Antimicrobial Agents and Chemotherapy.

[34]  L. Rice,et al.  Transferable, Plasmid-Mediated VanB-Type Glycopeptide Resistance in Enterococcus faecium , 1998, Antimicrobial Agents and Chemotherapy.

[35]  M. Bonten,et al.  A Novel Putative Enterococcal Pathogenicity Island Linked to the esp Virulence Gene of Enterococcus faecium and Associated with Epidemicity , 2004, Journal of bacteriology.

[36]  R. Willems,et al.  Influence of Transferable Genetic Determinants on the Outcome of Typing Methods Commonly Used for Enterococcus faecium , 2003, Journal of Clinical Microbiology.

[37]  C. Carlsson,et al.  Nosocomial outbreak of vanB2 vancomycin-resistant Enterococcus faecium in Sweden. , 2006, The Journal of hospital infection.

[38]  G. Jacoby,et al.  vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium , 2010, Antimicrobial Agents and Chemotherapy.

[39]  M. Gasson,et al.  Molecular Screening of EnterococcusVirulence Determinants and Potential for Genetic Exchange between Food and Medical Isolates , 2001, Applied and Environmental Microbiology.

[40]  P. Ward,et al.  Improved Detection of vanB2-Containing Enterococcus faecium with Vancomycin Susceptibility by Etest Using Oxgall Supplementation , 2008, Journal of Clinical Microbiology.

[41]  B. Söderquist,et al.  Clustering of polyclonal VanB‐type vancomycin‐resistant Enterococcus faecium in a low‐endemic area was associated with CC17‐genogroup strains harbouring transferable vanB2‐Tn5382 and pRUM‐like repA containing plasmids with axe‐txe plasmid addiction systems , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[42]  W. Witte,et al.  Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU , 2012, Antimicrobial Resistance and Infection Control.

[43]  M. Mulvey,et al.  Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel d-Ala-d-Ser Gene Cluster, vanL , 2008, Antimicrobial Agents and Chemotherapy.

[44]  Finbarr Hayes,et al.  Axe–Txe, a broad‐spectrum proteic toxin–antitoxin system specified by a multidrug‐resistant, clinical isolate of Enterococcus faecium , 2003, Molecular microbiology.

[45]  R. Arduino,et al.  Roles of antibodies and complement in phagocytic killing of enterococci , 1994, Infection and immunity.

[46]  F. Baquero,et al.  Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic Complex , 2005 .

[47]  M. Bonten,et al.  Five Genes Encoding Surface-Exposed LPXTG Proteins Are Enriched in Hospital-Adapted Enterococcus faecium Clonal Complex 17 Isolates , 2007, Journal of bacteriology.

[48]  K. Leder,et al.  Long-Term Carriage of Vancomycin-Resistant Enterococci in Patients Discharged from Hospitals: a 12-Year Retrospective Cohort Study , 2013, Journal of Clinical Microbiology.

[49]  A. Sundsfjord,et al.  Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences. , 2000, Microbiology.

[50]  J. Jonasson,et al.  Modified pulsed‐field gel electrophoresis protocol for typing of enterococci , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[51]  W. van Schaik,et al.  Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. , 2009, Future microbiology.

[52]  A. Sundsfjord,et al.  Increased high-level gentamicin resistance in invasive Enterococcus faecium is associated with aac(6')Ie-aph(2″)Ia-encoding transferable megaplasmids hosted by major hospital-adapted lineages. , 2012, FEMS immunology and medical microbiology.

[53]  W. Witte,et al.  High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). , 2010, International journal of antimicrobial agents.

[54]  B. Wretlind,et al.  Alterations in GyrA and ParC Associated with Fluoroquinolone Resistance in Enterococcus faecium , 1999, Antimicrobial Agents and Chemotherapy.

[55]  M. Hargreaves,et al.  Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates. , 2012, Systematic and applied microbiology.

[56]  M. Bonten,et al.  High-Level Ciprofloxacin Resistance from Point Mutations in gyrA and parC Confined to Global Hospital-Adapted Clonal Lineage CC17 of Enterococcus faecium , 2006, Journal of Clinical Microbiology.